NOTE 10: Earnings/Loss per Share Because we reported a net loss for all periods presented, no potentially dilutive securities have been included in the computation of diluted net loss per share. | | | Three months ended | | | | | June 30, | | | | | 2026 | | | 2025 | | | Numerators: | | | | | | | | Net loss attributable to common stockholders | | $ | (9,981 | ) | | $ | (1,650 | ) | | Denominator: | | | | | | | | | | Weighted Average shares used to compute basic and diluted net loss per share | | | 224,320,751 | | | | 119,585,747 | | | Basic and diluted net loss per share | | $ | (0.04 | ) | | $ | (0.01 | ) | | | | Nine Months Ended | | | | | June 30, | | | | | 2026 | | | 2025 | | | Numerators: | | | | | | | | Net loss attributable to common stockholders | | $ | (20,402 | ) | | $ | (31,749 | ) | | Denominator: | | | | | | | | | | Weighted Average shares used to compute basic and diluted net loss per share | | | 217,342,358 | | | | 110,225,078 | | | Basic and diluted net loss per share | | $ | (0.09 | ) | | $ | (0.29 | ) | The following potential common stock outstanding were excluded from the computation of diluted net loss per share because including them would have been anti-dilutive: | | | June 30,
2026 | | | September 30,
2025 | | | Warrants to purchase Class B common stock | | | 2,137,384 | | | | 6,623,330 | | | Unvested RSAs | | | 43,000 | | | | - | |
|